Matsumoto Taro, Mugishima Hideo
Division of Cell Regeneration and Transplantation, Advanced Medical Research Center, Nihon University School of Medicine, Tokyo, Japan.
J Atheroscler Thromb. 2006 Jun;13(3):130-5. doi: 10.5551/jat.13.130.
Vascular endothelial growth factor (VEGF)-A plays a critical role in vascular development and angiogenesis through its binding and activation of VEGF receptor-2 (VEGFR-2). The binding of VEGF-A to VEGFR-2 causes receptor dimerization, kinase activation and autophosphorylation of specific tyrosine residues within the dimeric complex. Tyrosine(Y)951 in the kinase-insert domain, Y1054 and Y1059 in the kinase domain and Y1175 and Y1214 in the C-terminal tail have been shown to serve as autophosphorylation sites. Phosphorylated Y1175 creates a binding site for phospholipase Cgamma1 (PLC-gamma1) and Shb. Activation of PLC-gamma1 and Shb regulates VEGF-A-dependent cell proliferation and cell migration, respectively. Phosphorylated Y951 binds and mediates tyrosine phosphorylation of the T-cell-specific adaptor protein (TSAd), which is expressed in endothelial cells. Y951-mediated coupling of VEGFR-2 and TSAd is critical for VEGF-A-induced cell migration and actin reorganization, and for pathological angiogenesis. These phosphorylation sites may be useful targets for the development of anti-angiogenic therapies to treat atherosclerosis and cancer.
血管内皮生长因子(VEGF)-A通过与血管内皮生长因子受体-2(VEGFR-2)结合并激活它,在血管发育和血管生成中发挥关键作用。VEGF-A与VEGFR-2的结合导致受体二聚化、激酶激活以及二聚体复合物内特定酪氨酸残基的自磷酸化。已证实,激酶插入结构域中的酪氨酸(Y)951、激酶结构域中的Y1054和Y1059以及C末端尾巴中的Y1175和Y1214作为自磷酸化位点。磷酸化的Y1175为磷脂酶Cγ1(PLC-γ1)和Shb创造了一个结合位点。PLC-γ1和Shb的激活分别调节VEGF-A依赖的细胞增殖和细胞迁移。磷酸化的Y951结合并介导T细胞特异性衔接蛋白(TSAd)的酪氨酸磷酸化,TSAd在内皮细胞中表达。Y951介导的VEGFR-2与TSAd的偶联对于VEGF-A诱导的细胞迁移和肌动蛋白重组以及病理性血管生成至关重要。这些磷酸化位点可能是开发治疗动脉粥样硬化和癌症的抗血管生成疗法的有用靶点。